カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ヒト肝臓モデルのグローバル市場展望 2023年-2029年：肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他

■ 英語タイトル：Human Liver Models Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8324）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8324
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：70
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒト肝臓モデルのグローバル市場展望 2023年-2029年：肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のヒト肝臓モデル市場規模と予測を収録しています。・世界のヒト肝臓モデル市場：売上、2018年-2023年、2024年-2029年
・世界のヒト肝臓モデル市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト肝臓モデル市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「肝臓オルガノイド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト肝臓モデルのグローバル主要企業は、Emulate、 Ascendance Bio、 InSphero、 CN Bio、 Organovo、 Cyfuse Biomedical、 Mimetasなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト肝臓モデルのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト肝臓モデル市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト肝臓モデル市場：タイプ別市場シェア、2022年
・肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他

世界のヒト肝臓モデル市場：用途別、2018年-2023年、2024年-2029年
世界のヒト肝臓モデル市場：用途別市場シェア、2022年
・創薬、教育、その他

世界のヒト肝臓モデル市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト肝臓モデル市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト肝臓モデルのグローバル売上、2018年-2023年
・主要企業におけるヒト肝臓モデルのグローバル売上シェア、2022年
・主要企業におけるヒト肝臓モデルのグローバル販売量、2018年-2023年
・主要企業におけるヒト肝臓モデルのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Emulate、 Ascendance Bio、 InSphero、 CN Bio、 Organovo、 Cyfuse Biomedical、 Mimetas

*************************************************************

・調査・分析レポートの概要
ヒト肝臓モデル市場の定義
市場セグメント
世界のヒト肝臓モデル市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト肝臓モデル市場規模
世界のヒト肝臓モデル市場規模：2022年 VS 2029年
世界のヒト肝臓モデル市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト肝臓モデルの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト肝臓モデル製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他
ヒト肝臓モデルのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：創薬、教育、その他
ヒト肝臓モデルの用途別グローバル売上・予測

・地域別市場分析
地域別ヒト肝臓モデル市場規模 2022年と2029年
地域別ヒト肝臓モデル売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Emulate、 Ascendance Bio、 InSphero、 CN Bio、 Organovo、 Cyfuse Biomedical、 Mimetas
...

Liver is a vital organ that performs several important bodily functions including bile production for digestion, protein production, synthesis of blood clotting factors, storage of glucose (sugar) in the form glycogen, and detoxification. Also, the liver cells have a remarkable ability to regenerate themselves after any damage. Due to this unique capability, the liver tissues have fascinated the researchers. True understanding of molecular and cellular connectivity and functions of the liver tissues in an in-vivo as well as in-vitro setting is very important from the viewpoint of discovery science and clinical application. Development of liver models that can provide a virtual ecosystem that mimics the molecular processes of a liver factory can help understand molecular interactions to network dynamics and whole organ functions. These advanced liver models are mini-organs or organoids that are expected to replicate human liver physiology, anatomy, and functions from molecular layer upward. The formation of these living models is a fairly new area of science that has the potential to replace animal models. The human liver models offer several advantages over animal models that are not always accurate and pose ethical issues. The human liver models or organoids have been used to screen new drugs for liver toxicity. These models are also being deeply studied to build a functional model of human liver development. The process of making a human liver model starts with a fetal liver progenitor cell, an immature cell that transforms into a specialized liver cell. The fetal liver progenitor cell is allowed to self-assemble in a small disc. These discs are composed of ferret liver cells that are pre-processed to remove all cells of the ferret. The resultant mini-organ models the actual human liver development. These models have been observed to generate hepatocytes, the basic functional cells of the liver, which is expected to produce the functional bioengineered liver tissues for transplantation into patients in the near future.
This report aims to provide a comprehensive presentation of the global market for Human Liver Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Liver Models. This report contains market size and forecasts of Human Liver Models in global, including the following market information:
Global Human Liver Models Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Liver Models Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Human Liver Models companies in 2022 (%)
The global Human Liver Models market was valued at US$ 1613.6 million in 2022 and is projected to reach US$ 3251.4 million by 2029, at a CAGR of 10.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American segment accounted for the largest share of the market in 2018. The human liver market for North America is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, increasing government funding, growing incidence of NAFLD, and unavailability of livers for transplantation, increasing investments on research, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Liver Models manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Liver Models Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Liver Models Market Segment Percentages, by Type, 2022 (%)
Liver Organoids
Liver-on-a-chip
2D Models
3D Bioprinting
Others
Global Human Liver Models Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Liver Models Market Segment Percentages, by Application, 2022 (%)
Drug Discovery
Education
Others
Global Human Liver Models Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Human Liver Models Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Liver Models revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Liver Models revenues share in global market, 2022 (%)
Key companies Human Liver Models sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Human Liver Models sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Emulate
Ascendance Bio
InSphero
CN Bio
Organovo
Cyfuse Biomedical
Mimetas
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Liver Models, market overview.
Chapter 2: Global Human Liver Models market size in revenue and volume.
Chapter 3: Detailed analysis of Human Liver Models manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Liver Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Liver Models capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Human Liver Models Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Liver Models Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Liver Models Overall Market Size
2.1 Global Human Liver Models Market Size: 2022 VS 2029
2.2 Global Human Liver Models Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Liver Models Sales: 2018-2029
3 Company Landscape
3.1 Top Human Liver Models Players in Global Market
3.2 Top Global Human Liver Models Companies Ranked by Revenue
3.3 Global Human Liver Models Revenue by Companies
3.4 Global Human Liver Models Sales by Companies
3.5 Global Human Liver Models Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Liver Models Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Liver Models Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Liver Models Players in Global Market
3.8.1 List of Global Tier 1 Human Liver Models Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Liver Models Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Liver Models Market Size Markets, 2022 & 2029
4.1.2 Liver Organoids
4.1.3 Liver-on-a-chip
4.1.4 2D Models
4.1.5 3D Bioprinting
4.1.6 Others
4.2 By Type – Global Human Liver Models Revenue & Forecasts
4.2.1 By Type – Global Human Liver Models Revenue, 2018-2023
4.2.2 By Type – Global Human Liver Models Revenue, 2024-2029
4.2.3 By Type – Global Human Liver Models Revenue Market Share, 2018-2029
4.3 By Type – Global Human Liver Models Sales & Forecasts
4.3.1 By Type – Global Human Liver Models Sales, 2018-2023
4.3.2 By Type – Global Human Liver Models Sales, 2024-2029
4.3.3 By Type – Global Human Liver Models Sales Market Share, 2018-2029
4.4 By Type – Global Human Liver Models Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Liver Models Market Size, 2022 & 2029
5.1.2 Drug Discovery
5.1.3 Education
5.1.4 Others
5.2 By Application – Global Human Liver Models Revenue & Forecasts
5.2.1 By Application – Global Human Liver Models Revenue, 2018-2023
5.2.2 By Application – Global Human Liver Models Revenue, 2024-2029
5.2.3 By Application – Global Human Liver Models Revenue Market Share, 2018-2029
5.3 By Application – Global Human Liver Models Sales & Forecasts
5.3.1 By Application – Global Human Liver Models Sales, 2018-2023
5.3.2 By Application – Global Human Liver Models Sales, 2024-2029
5.3.3 By Application – Global Human Liver Models Sales Market Share, 2018-2029
5.4 By Application – Global Human Liver Models Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Human Liver Models Market Size, 2022 & 2029
6.2 By Region – Global Human Liver Models Revenue & Forecasts
6.2.1 By Region – Global Human Liver Models Revenue, 2018-2023
6.2.2 By Region – Global Human Liver Models Revenue, 2024-2029
6.2.3 By Region – Global Human Liver Models Revenue Market Share, 2018-2029
6.3 By Region – Global Human Liver Models Sales & Forecasts
6.3.1 By Region – Global Human Liver Models Sales, 2018-2023
6.3.2 By Region – Global Human Liver Models Sales, 2024-2029
6.3.3 By Region – Global Human Liver Models Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Human Liver Models Revenue, 2018-2029
6.4.2 By Country – North America Human Liver Models Sales, 2018-2029
6.4.3 US Human Liver Models Market Size, 2018-2029
6.4.4 Canada Human Liver Models Market Size, 2018-2029
6.4.5 Mexico Human Liver Models Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Human Liver Models Revenue, 2018-2029
6.5.2 By Country – Europe Human Liver Models Sales, 2018-2029
6.5.3 Germany Human Liver Models Market Size, 2018-2029
6.5.4 France Human Liver Models Market Size, 2018-2029
6.5.5 U.K. Human Liver Models Market Size, 2018-2029
6.5.6 Italy Human Liver Models Market Size, 2018-2029
6.5.7 Russia Human Liver Models Market Size, 2018-2029
6.5.8 Nordic Countries Human Liver Models Market Size, 2018-2029
6.5.9 Benelux Human Liver Models Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Human Liver Models Revenue, 2018-2029
6.6.2 By Region – Asia Human Liver Models Sales, 2018-2029
6.6.3 China Human Liver Models Market Size, 2018-2029
6.6.4 Japan Human Liver Models Market Size, 2018-2029
6.6.5 South Korea Human Liver Models Market Size, 2018-2029
6.6.6 Southeast Asia Human Liver Models Market Size, 2018-2029
6.6.7 India Human Liver Models Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Human Liver Models Revenue, 2018-2029
6.7.2 By Country – South America Human Liver Models Sales, 2018-2029
6.7.3 Brazil Human Liver Models Market Size, 2018-2029
6.7.4 Argentina Human Liver Models Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Human Liver Models Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Human Liver Models Sales, 2018-2029
6.8.3 Turkey Human Liver Models Market Size, 2018-2029
6.8.4 Israel Human Liver Models Market Size, 2018-2029
6.8.5 Saudi Arabia Human Liver Models Market Size, 2018-2029
6.8.6 UAE Human Liver Models Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Emulate
7.1.1 Emulate Company Summary
7.1.2 Emulate Business Overview
7.1.3 Emulate Human Liver Models Major Product Offerings
7.1.4 Emulate Human Liver Models Sales and Revenue in Global (2018-2023)
7.1.5 Emulate Key News & Latest Developments
7.2 Ascendance Bio
7.2.1 Ascendance Bio Company Summary
7.2.2 Ascendance Bio Business Overview
7.2.3 Ascendance Bio Human Liver Models Major Product Offerings
7.2.4 Ascendance Bio Human Liver Models Sales and Revenue in Global (2018-2023)
7.2.5 Ascendance Bio Key News & Latest Developments
7.3 InSphero
7.3.1 InSphero Company Summary
7.3.2 InSphero Business Overview
7.3.3 InSphero Human Liver Models Major Product Offerings
7.3.4 InSphero Human Liver Models Sales and Revenue in Global (2018-2023)
7.3.5 InSphero Key News & Latest Developments
7.4 CN Bio
7.4.1 CN Bio Company Summary
7.4.2 CN Bio Business Overview
7.4.3 CN Bio Human Liver Models Major Product Offerings
7.4.4 CN Bio Human Liver Models Sales and Revenue in Global (2018-2023)
7.4.5 CN Bio Key News & Latest Developments
7.5 Organovo
7.5.1 Organovo Company Summary
7.5.2 Organovo Business Overview
7.5.3 Organovo Human Liver Models Major Product Offerings
7.5.4 Organovo Human Liver Models Sales and Revenue in Global (2018-2023)
7.5.5 Organovo Key News & Latest Developments
7.6 Cyfuse Biomedical
7.6.1 Cyfuse Biomedical Company Summary
7.6.2 Cyfuse Biomedical Business Overview
7.6.3 Cyfuse Biomedical Human Liver Models Major Product Offerings
7.6.4 Cyfuse Biomedical Human Liver Models Sales and Revenue in Global (2018-2023)
7.6.5 Cyfuse Biomedical Key News & Latest Developments
7.7 Mimetas
7.7.1 Mimetas Company Summary
7.7.2 Mimetas Business Overview
7.7.3 Mimetas Human Liver Models Major Product Offerings
7.7.4 Mimetas Human Liver Models Sales and Revenue in Global (2018-2023)
7.7.5 Mimetas Key News & Latest Developments
8 Global Human Liver Models Production Capacity, Analysis
8.1 Global Human Liver Models Production Capacity, 2018-2029
8.2 Human Liver Models Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Liver Models Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Liver Models Supply Chain Analysis
10.1 Human Liver Models Industry Value Chain
10.2 Human Liver Models Upstream Market
10.3 Human Liver Models Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Liver Models Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト肝臓オンチップのグローバル市場展望 2023年-2029年：電気刺激法、機械刺激法、その他
  • 世界のヒト肝臓モデル市場2022年：市場規模予測（～2028年）
  • 肝臓用サプリメントのグローバル市場展望 2023年-2029年：錠剤、粉末、液体
  • 肝臓がんスクリーニング装置のグローバル市場展望 2023年-2029年：血液検査、画像検査
  • ノックアウトマウスモデルのグローバル市場展望 2023年-2029年：KO、cKO
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8324 )"ヒト肝臓モデルのグローバル市場展望 2023年-2029年：肝臓オルガノイド、肝臓オンチップ、2Dモデル、3Dバイオプリンティング、その他" (英文：Human Liver Models Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。